Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer

Takayuki Shiroyama,Takashi Kijima,Kiyoshi Komuta,Suguru Yamamoto,Seigo Minami,Yoshitaka Ogata,Kouhei Okafuji,Fumio Imamura,Tomonori Hirashima,Isao Tachibana,Ichiro Kawase,Atsushi Kumanogoh

Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer

2012

Takayuki Shiroyama
Takashi Kijima
Kiyoshi Komuta
Suguru Yamamoto
Seigo Minami
Yoshitaka Ogata
Kouhei Okafuji
Fumio Imamura
Tomonori Hirashima
Isao Tachibana
Ichiro Kawase
Atsushi Kumanogoh

Purpose We investigated the efficacy and toxicity of a novel oral 5-fluorouracil (5-FU) formulation (S-1), administered according to a tailored dose regimen.

Keywords:

Recurrent Non-Small Cell Lung Cancer
Regimen
Pharmacology
Oncology
Pharmacokinetics
Chemotherapy
Internal medicine
Medicine
Toxicity
Cancer
Renal function
Cmax
Confidence interval
Body surface area

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations